DUC: Delayed Umbilical Cord Clamping in Infants Less Than 32 Weeks
Study Details
Study Description
Brief Summary
The overall objective of the present study is to examine the effects of delayed umbilical cord clamping in preterm infants on neonatal outcomes using a prospective randomized controlled trial comparing immediate cord clamping (standard at present) with delayed cord clamping.
Our specific aim is to determine if a 30 to 45 second delay in umbilical cord clamping improves neonatal outcome as assessed by a composite of intraventricular hemorrhage and late onset sepsis in preterm infants born between 24 and 32 weeks gestation. Secondary outcomes to be examined include improvements in the following: 1) lung function as assessed by oxygen dependency at 36 weeks corrected gestational age (CGA), 2) cardiovascular function as assessed by the need for volume expansion, inotropes, or clinically suspected PDA requiring intervention prior to discharge home, and 3) anemia as assessed by initial hemoglobin, need for transfusion during stay in the NICU, and number of transfusions.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
N/A |
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Experimental: A 1 Delayed umbilical cord clamping 30-45 seconds. |
Procedure: Umbilical cord clamping
Delay of umbilical cord clamping 30 to 45 seconds
|
No Intervention: A 2 Immediate umbilibcal cord clamping |
Outcome Measures
Primary Outcome Measures
- Primary Composite outcome of Intraventricular Hemorrhage and/or Late Onset Sepsis [3 years]
Secondary Outcome Measures
- Secondary outcomes include: 1) lung function 2) cardiovascular function and 3) anemia. [3 years]
Eligibility Criteria
Criteria
Inclusion Criteria:
-
Women in labour or with a plan for delivery at a gestational age between 24 0/7 to 32 0/7 weeks gestation.
-
Singleton pregnancy (Note: if pregnancy was a multiple gestation but demised occurred prior to 13 weeks, these patients can be included in study).
Exclusion Criteria:
-
Moderate to life threatening fetal anomalies
-
Multiple live gestations at birth (e.g. twins, triplets, etc)
-
Intrauterine fetal demise
-
Previous participation
-
Stem cell collection
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Mount Sinai Hospital | Toronto | Ontario | Canada | M5G 1X5 |
Sponsors and Collaborators
- Mount Sinai Hospital, Canada
Investigators
- Principal Investigator: Kellie E Murphy, MD MSc, Mount Sinai Hospital, Canada
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- Mount Sinai Hospital Toronto